MY143563A - New association of an if sinusoidal current inhibitor and a calcium channel-blocking agent, and pharmaceutical ingredients containing said association - Google Patents

New association of an if sinusoidal current inhibitor and a calcium channel-blocking agent, and pharmaceutical ingredients containing said association

Info

Publication number
MY143563A
MY143563A MYPI20064723A MYPI20064723A MY143563A MY 143563 A MY143563 A MY 143563A MY PI20064723 A MYPI20064723 A MY PI20064723A MY PI20064723 A MYPI20064723 A MY PI20064723A MY 143563 A MY143563 A MY 143563A
Authority
MY
Malaysia
Prior art keywords
association
blocking agent
calcium channel
pharmaceutical ingredients
sinusoidal current
Prior art date
Application number
MYPI20064723A
Other languages
English (en)
Inventor
Vidal Benatar
Guy Lerebours-Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37075950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY143563(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of MY143563A publication Critical patent/MY143563A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MYPI20064723A 2005-12-21 2006-12-20 New association of an if sinusoidal current inhibitor and a calcium channel-blocking agent, and pharmaceutical ingredients containing said association MY143563A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513008A FR2894826B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
MY143563A true MY143563A (en) 2011-05-31

Family

ID=37075950

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20064723A MY143563A (en) 2005-12-21 2006-12-20 New association of an if sinusoidal current inhibitor and a calcium channel-blocking agent, and pharmaceutical ingredients containing said association

Country Status (41)

Country Link
US (3) US20070142356A1 (sr)
EP (1) EP1800683B1 (sr)
JP (2) JP4783275B2 (sr)
KR (1) KR100907584B1 (sr)
CN (1) CN101015556B (sr)
AP (1) AP2208A (sr)
AR (1) AR058575A1 (sr)
AT (1) ATE488239T1 (sr)
AU (1) AU2006252211B2 (sr)
BR (1) BRPI0605516A (sr)
CA (1) CA2571649C (sr)
CO (1) CO5790167A1 (sr)
CR (1) CR8813A (sr)
CY (1) CY1111007T1 (sr)
DE (1) DE602006018247D1 (sr)
DK (1) DK1800683T3 (sr)
EA (1) EA013536B1 (sr)
ES (1) ES2356660T3 (sr)
FR (1) FR2894826B1 (sr)
GE (1) GEP20094603B (sr)
GT (1) GT200600523A (sr)
HR (1) HRP20110028T1 (sr)
IL (1) IL180209A (sr)
JO (1) JO2675B1 (sr)
MA (1) MA28724B1 (sr)
MX (1) MXPA06014884A (sr)
MY (1) MY143563A (sr)
NO (1) NO337509B1 (sr)
NZ (1) NZ552222A (sr)
PE (1) PE20071133A1 (sr)
PL (1) PL1800683T3 (sr)
PT (1) PT1800683E (sr)
PY (1) PY0639427A (sr)
RS (1) RS51534B (sr)
SA (1) SA06270482B1 (sr)
SG (1) SG133546A1 (sr)
SI (1) SI1800683T1 (sr)
TW (1) TWI373344B (sr)
UA (1) UA91507C2 (sr)
WO (1) WO2007077329A2 (sr)
ZA (1) ZA200610822B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
FR2920773B1 (fr) 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
WO2009158005A1 (en) * 2008-06-27 2009-12-30 Concert Pharmaceuticals, Inc. Benzazepinone compounds
FR2938194B1 (fr) * 2008-11-07 2012-08-31 Servier Lab Utilisation de l'ivabradine comme agent de diagnostic dans la methode d'angiographie coronaire par tomodensitometrie multicoupe
RU2392940C1 (ru) * 2009-03-23 2010-06-27 Государственное образовательное учреждение дополнительного профессионального образования Санкт-Петербургская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию Способ лечения брадиаритмии, вызванной атриовентрикулярными блокадами

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US20030092745A1 (en) * 2000-02-25 2003-05-15 Pfizer Inc. Combination therapy
WO2003024457A1 (en) * 2001-09-11 2003-03-27 Asahi Kasei Kabushiki Kaisha Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy
AR037565A1 (es) * 2001-11-21 2004-11-17 Synthon Bv Formas de sales de amlodipina y procedimientos para prepararlas.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
KR100907584B1 (ko) 2009-07-14
JO2675B1 (en) 2012-06-17
JP4783275B2 (ja) 2011-09-28
FR2894826B1 (fr) 2010-10-22
AP2208A (en) 2011-02-23
DK1800683T3 (da) 2011-03-07
EA013536B1 (ru) 2010-06-30
ES2356660T3 (es) 2011-04-12
GEP20094603B (en) 2009-02-10
IL180209A0 (en) 2008-01-20
WO2007077329A2 (fr) 2007-07-12
CA2571649C (fr) 2012-05-22
DE602006018247D1 (de) 2010-12-30
JP2007169284A (ja) 2007-07-05
AU2006252211B2 (en) 2012-05-17
PE20071133A1 (es) 2007-12-22
EP1800683A1 (fr) 2007-06-27
TW200744637A (en) 2007-12-16
SI1800683T1 (sl) 2011-01-31
WO2007077329A3 (fr) 2007-09-07
UA91507C2 (ru) 2010-08-10
US20090215745A1 (en) 2009-08-27
BRPI0605516A (pt) 2007-10-16
MA28724B1 (fr) 2007-07-02
KR20070066922A (ko) 2007-06-27
CA2571649A1 (fr) 2007-06-21
CN101015556A (zh) 2007-08-15
SG133546A1 (en) 2007-07-30
SA06270482B1 (ar) 2011-06-22
EA200602156A1 (ru) 2007-08-31
RS51534B (sr) 2011-06-30
HK1106442A1 (en) 2008-03-14
JP2011068661A (ja) 2011-04-07
NO337509B1 (no) 2016-05-02
PL1800683T3 (pl) 2011-04-29
CR8813A (es) 2007-06-06
AU2006252211A1 (en) 2007-07-05
ZA200610822B (en) 2008-06-25
AP2006003858A0 (en) 2006-12-31
NZ552222A (en) 2008-05-30
US20110230466A1 (en) 2011-09-22
MXPA06014884A (es) 2009-02-11
US20070142356A1 (en) 2007-06-21
IL180209A (en) 2015-05-31
NO20065903L (no) 2007-06-22
EP1800683B1 (fr) 2010-11-17
ATE488239T1 (de) 2010-12-15
GT200600523A (es) 2007-07-25
CO5790167A1 (es) 2007-08-31
CN101015556B (zh) 2011-08-10
PY0639427A (es) 2013-04-01
TWI373344B (en) 2012-10-01
FR2894826A1 (fr) 2007-06-22
AR058575A1 (es) 2008-02-13
CY1111007T1 (el) 2015-06-11
PT1800683E (pt) 2010-12-17
HRP20110028T1 (hr) 2011-02-28

Similar Documents

Publication Publication Date Title
BR0212921A (pt) Composição farmacêutica com base em fondant
MXPA05007328A (es) Composiciones que contienen agentes antiacne y el uso de las mismas.
EA200701790A1 (ru) Твёрдый фармацевтический дозированный состав
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
EE200300121A (et) CB1 retseptori antagonisti ja sibutramiini kombinatsioon, neid sisaldav farmatseutiline kompositsioon ja kasutamine lihavuse raviks
PA8513601A1 (es) Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa
BRPI0408221A (pt) dispositivos dispensadores
JO2578B1 (en) Compounds Theophene benzimidazole
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
DE60310936D1 (de) Riechstoffzusammensetzung
TW200738283A (en) Formulations of conjugated estrogens and bazedoxifene
MXPA05008099A (es) Productos n-aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
MY143563A (en) New association of an if sinusoidal current inhibitor and a calcium channel-blocking agent, and pharmaceutical ingredients containing said association
TW200531686A (en) Pharmaceutical compositions
HUP0400438A3 (en) Broadspectrum 2-amino-benzoxazole-6-sulfonamides, their use as hiv protease inhibitor and pharmaceutical compositions containing them
TW200517117A (en) Stabilized compositions containing an oxygen-labile active agent
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
ATE477802T1 (de) Tablettenförmige retardzubereitung enthaltend cinnarizin und dimenhydrinat gegen schwindel
MXPA02010828A (es) Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
TW200733954A (en) Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.
WO2008015202A3 (en) Anticonvulsive pharmaceutical compositions
MA27364A1 (fr) Compositions contenant des principes actifs adoucissants specifiques